Healthcare Bizdev
HCBD-Pro Services Client Subscribers

HCBD-PRO Services

Query News -

Welcome <Guest> Login
back to News
 
Highmark Inc. signs outcomes-based agreement with AstraZeneca for Symbicort

Source Highmark Inc.
Published Date 4/17/2018
One of the first agreements announced in respiratory

Highmark Inc. has entered into an outcomes-based contract with AstraZeneca for the well-known medicine Symbicort®. Indicated for the treatment of asthma and chronic obstructive pulmonary disease (COPD), Symbicort helps decrease inflammation and open up the airways in patients' lungs. ...
View the entire Highmark Inc. article
    LinkedIn
 
Featured Companies
Highmark Inc.
Pittsburgh, PA
 

Company Representatives Featured
Ryan Cox
[Director of Clinical Pharmacy Services]
Highmark Inc.
 
Leilyn Perri
[Corporate Media Relations Director]
Highmark Blue Shield
 
Rick Suarez
[VP, Market Access]
AstraZeneca
 
 
back to News
About Us | Purchase Pro | Contact Us

© 2006-2010 Healthcare BizDev, Inc. All rights reserved. Privacy Policy | Legal Conditions